Accuracy to the n^th degree with Tecan’s Freedom EVO® platform

 

 

 

 

 

 

 

 

 

 

 

 

 

The speed and accuracy of Tecan’s Freedom EVO liquid handling workstation is helping researchers at Quanterix Corporation in Cambridge, Massachusetts, to develop their revolutionary SiMoA™ (Single Molecule Array) technology.

 

Jeffrey Randall is principal scientist at Quanterix, and explained why they chose the Freedom EVO workstation: “Our SiMoA technology allows us to detect single molecules, making it ideal for the quantification of low abundance analytes and biomarkers. Accurate control of pipetting volumes is important to us because our assays are at least 1,000 times more sensitive than traditional bulk ELISA. The Freedom EVO platform offers very reproducible pipetting, allowing us to ramp up throughput without sacrificing consistency, something we could not achieve with other automated liquid handling systems we looked at.”

 

Todd Campbell, senior automation engineer, added: “We use the platform as a research and development tool to optimize our assays. The Freedom EVO offers the flexibility we need to make these changes because protocols are continuously evolving. The software is extremely easy to use and this, combined with Tecan’s excellent support, has enabled us to develop our system very quickly to begin sample testing.”

 

To find out more on Tecan’s Freedom EVO liquid handling workstations, visit www.tecan.com/freedomevo

     

 

 

 

For more information about Tecan, please contact:

 

 

 

About Tecan

Tecan (www.tecan.com) is a leading global supplier of laboratory instruments and solutions for the biopharma, forensic and diagnostic industries. The company specializes in the development, production and distribution of automation solutions for life science laboratories. Through its REMP subsidiary (www.remp.com), Tecan is the premier supplier of automated laboratory storage and logistics systems. Tecan's clients include pharmaceutical and biotech companies, university research departments, diagnostic laboratories and companies as well as forensics laboratories. Founded in Switzerland in 1980, the company has production, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2007, Tecan achieved sales of CHF 414.4 million (USD 345.3 million; EUR 252.7 million). Registered shares of the Tecan Group are traded on the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Valor: 1210019).